Phase I Single and Multiple dose Safety and Pharmacokine - Steven Zeisel

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: Division of Cancer Prevention And Control (NCI)
Type: Research and Development Contracts (N01)
Project #: N01CN065117-004
Application #: 6346805
Study Section

Project Start: 1996-09-30
Project End: 2000-11-30
Budget Start: 2000-08-23
Budget End: 2000-11-30
Support Year
Fiscal Year: 1999
Total Cost
Indirect Cost

Institution

Name: University of North Carolina Chapel Hill
Department: Nutrition
Type: Schools of Public Health
DUNS #: 078861598

City: Chapel Hill
State: NC
Country: United States
Zip Code: 27599

Related projects


NIH 2000 N01 CN	Phase I Single and Multiple dose Safety and Pharmacokine Zeisel, Steven H. / University of North Carolina Chapel Hill	$130,000
NIH 1999 N01 CN	Phase I Single and Multiple dose Safety and Pharmacokine Zeisel, Steven H. / University of North Carolina Chapel Hill
NIH 1998 N01 CN	Phase I Single and Multiple dose Safety and Pharmacokine Zeisel, Steven H. / University of North Carolina Chapel Hill
NIH 1996 N01 CN	Phase I Single and Multiple dose Safety and Pharmacokine Zeisel, Steven H. / University of North Carolina Chapel Hill

Publications

Fischer, Leslie; Mahoney, Chrysa; Jeffcoat, A Robert et al. (2004) Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia. Nutr Cancer 48:160-70

Busby, Marjorie G; Jeffcoat, A Robert; Bloedon, LeAnne T et al. (2002) Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 75:126-36

Comments

Be the first to comment on Steven Zeisel's grant